The reagent kit Immunochromatographic test system for the
qualitative detection of IgM / IgG antibodies to SARS-CoV*2
coronavirus in human serum, plasma or whole blood samples
SARS-CoV*2 IgM/IgG Screen is intended for
one-stage rapid qualitative detection IgM and / or IgG to
SARS-CoV*2 coronavirus in human serum, plasma or whole blood
samples in individuals with clinical symptoms of respiratory
disease with suspected COVID**9 infection, as well as in
individuals who do not have signs of colds and are not contact with
patients with COVID****9 by the method of immunochromatographic
analysis (LFIA). Functional purpose:
The kit is used as an aid in the diagnosis. Antibody test results
should not be used as the sole basis for confirming or excluding
SARS-CoV*2 infection, or for reporting infection status.
For single use of the test for its intended use.
For clinical In Vitro Diagnostics.
